Literature DB >> 12007580

Methionine synthase. a possible prime site of the ethanolic lesion in liver.

Anthony J Barak1, Harriet C Beckenhauer, Dean J Tuma.   

Abstract

Among the most important pathways for liver integrity in the body are the two that synthesize methionine and S-adenosylmethionine (SAM) through methylation of homocysteine. Results of studies in this laboratory have demonstrated ethanolic inhibition of one of these pathways catalyzed by methionine synthetase. It has been shown elsewhere that alcohol per se does not inhibit the enzyme, but that the metabolite of ethanol, acetaldehyde, is responsible through the formation of an inhibiting covalent adduct. Because hepatic SAM has been shown to be essential in the transport of fat from the liver, avoiding steatosis and further liver damage, it is entirely feasible that this repression of methionine synthase is an important site of the injurious action of alcohol metabolism in the liver. This loss of activity is particularly important in human beings who cannot produce methionine and SAM by means of the alternate pathway mediated by betaine:homocysteine:transmethylase, because of the lack of production of the betaine substrate for this enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007580     DOI: 10.1016/s0741-8329(01)00201-4

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  23 in total

Review 1.  Epigenetic regulation in alcoholic liver disease.

Authors:  Pranoti Mandrekar
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  The redox basis of epigenetic modifications: from mechanisms to functional consequences.

Authors:  Anthony R Cyr; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2011-02-05       Impact factor: 8.401

3.  Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase.

Authors:  Janet D Sparks; Heidi L Collins; Doru V Chirieac; Joanne Cianci; Jenny Jokinen; Mark P Sowden; Chad A Galloway; Charles E Sparks
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

4.  Ethanol lowers glutathione in rat liver and brain and inhibits methionine synthase in a cobalamin-dependent manner.

Authors:  Mostafa I Waly; Kusum K Kharbanda; Richard C Deth
Journal:  Alcohol Clin Exp Res       Date:  2010-12-01       Impact factor: 3.455

Review 5.  Epigenetic effects of ethanol on liver and gastrointestinal injury.

Authors:  Shivendra D Shukla; Annayya R Aroor
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

Review 6.  "Second hit" models of alcoholic liver disease.

Authors:  Hidekazu Tsukamoto; Keigo Machida; Alla Dynnyk; Hasmik Mkrtchyan
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

7.  The association between betaine and choline intakes and the plasma concentrations of homocysteine in women.

Authors:  Stephanie E Chiuve; Edward L Giovannucci; Susan E Hankinson; Steven H Zeisel; Lauren W Dougherty; Walter C Willett; Eric B Rimm
Journal:  Am J Clin Nutr       Date:  2007-10       Impact factor: 7.045

8.  The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.

Authors:  Maxwell Afari Gyamfi; Ivan Damjanov; Samuel French; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2007-10-18       Impact factor: 5.858

9.  In vitro inhibition of 10-formyltetrahydrofolate dehydrogenase activity by acetaldehyde.

Authors:  Ju-Ae Mun; Eunjin Doh; Hyesun Min
Journal:  Nutr Res Pract       Date:  2008-12-31       Impact factor: 1.926

10.  Proteomics reveal a concerted upregulation of methionine metabolic pathway enzymes, and downregulation of carbonic anhydrase-III, in betaine supplemented ethanol-fed rats.

Authors:  Kusum K Kharbanda; Vasanthy Vigneswara; Benita L McVicker; Anna U Newlaczyl; Kevin Bailey; Dean Tuma; David E Ray; Wayne G Carter
Journal:  Biochem Biophys Res Commun       Date:  2009-02-23       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.